For research use only. Not for therapeutic Use.
DA-11004(CAT: I025477) is a promising compound under investigation for its potential therapeutic applications in gastrointestinal disorders, particularly gastroesophageal reflux disease (GERD). It acts as a potassium-competitive acid blocker (P-CAB), selectively and effectively inhibiting gastric H+^+/K+^+-ATPase activity to suppress acid secretion. DA-11004 offers advantages over traditional proton pump inhibitors (PPIs) with its rapid onset of action and sustained acid suppression. This compound is a valuable tool in preclinical and clinical research to explore novel treatments for acid-related diseases, providing insights into optimizing therapeutic strategies for improved patient outcomes.
Catalog Number | I025477 |
CAS Number | 57404-51-0 |
Synonyms | DA-11004; DA 11004; DA11004; UNII-48M66E9ER2; |
Molecular Formula | C11H9NO2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 1,2-Naphthalenedione, 4-(methylamino)- |
InChI | InChI=1S/C11H9NO2/c1-12-9-6-10(13)11(14)8-5-3-2-4-7(8)9/h2-6,12H,1H3 |
InChIKey | BPGSNZXXCCSOAN-UHFFFAOYSA-N |
SMILES | O=C1C(C=C(NC)C2=C1C=CC=C2)=O |